Resultados de la búsqueda 441-450 of 13473 for Drug use

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab attaches to cancer cells in a targeted way and delivers calicheamicin to kill them. Other drugs used in the chemotherapy regimen, such as ...

2. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

   Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by ...

3. Oncología (médica) - Ensayos clínicos

   Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab attaches to cancer cells in a targeted way and delivers calicheamicin to kill them. Other drugs used in the chemotherapy regimen, such as ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab attaches to cancer cells in a targeted way and delivers calicheamicin to kill them. Other drugs used in the chemotherapy regimen, such as ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab attaches to cancer cells in a targeted way and delivers calicheamicin to kill them. Other drugs used in the chemotherapy regimen, such as ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by ...

8. Cirugía - Ensayos clínicos - Mayo Clinic

   Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by ...

10. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD. Accurate, MR based kidney volume measurements are the ...